Advertisement

Topics

NC GlaxoSmithKline Foundation Company Profile

22:06 EDT 24th June 2018 | BioPortfolio


News Articles [772 Associated News Articles listed on BioPortfolio]

GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV

LONDON (dpa-AFX) - GlaxoSmithKline PLC (GSK.L, GSK) reported that ViiV Healthcare, a specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholder...

Quotidian Technical Highlights on Selected Healthcare Stocks -- GlaxoSmithKline, Synergy ...

www.wallstequities.com/registration GlaxoSmithKline On Wednesday, shares in Brentford, the UK headquartered GlaxoSmithKline PLC recorded a trading volume of 3.89 million shares. The stock ended at...

GlaxoSmithKline Is Taking a Tough Approach to Budgets

The head of GlaxoSmithKline's pharmaceuticals division is pushing to cut its budget by 20 percent.

GlaxoSmithKline is Eyeing Pfizer's $15B+ Consumer Biz

GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay.

UBS belässt GlaxoSmithKline auf 'Buy'

Die Schweizer Großbank UBS hat die Einstufung für GlaxoSmithKline auf "Buy" belassen. Die europäischen Pharmakonzerne stünden weiter vor strukturellen Herausforderungen, dürften im Jahr 2018 aber...

Glaxosmithkline will trotz Quartalsverlust Dividendenversprechen halten

Von Carlo Martuscelli LONDON (Dow Jones)--Glaxosmithkline ist wegen einer Belastung im Zuge der US-Steuerreform im vierten Quartal in die Verlustzone gerutscht. An der in Aussicht gestellten Divid...

GlaxoSmithKline prescribes commercial reboot for pharma division

LONDON (Reuters) - In January, GlaxoSmithKline's new head of pharmaceuticals Luke Miels issued a blunt challenge to his managers: find budget savings of 20 percent.

Glaxosmithkline bestätigt trotz Gewinneinbruch Prognose

Von Carlo Martuscelli LONDON (Dow Jones)--Glaxosmithkline hat im ersten Quartal einen Gewinnrückgang um nahezu 50 Prozent verzeichnet. Dennoch hält der britische Pharmakonzern an seiner Jahresprog.....

Clinical Trials [410 Associated Clinical Trials listed on BioPortfolio]

Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer

This study compared a plant-based, olive oil diet to the diet recommended by the Prostate Cancer Foundation for weight loss and improvement in some laboratory biomarkers.

Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine 580299 in Healthy Females 10 - 25 Years of Age.

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to assess the immunogenicity and safety of Gla...

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix TM) in HIV Infected Females

Infection with human papillomavirus (HPV) has been clearly established as the central cause of cervical cancer. The current study is designed to evaluate the safety and immunogenicity of G...

Operating Check List During Consultation for Dental Implant

Various studies showed how extent elements not directly linked to the state of the patient were involved in the failures in particular in surgery. That's why it's common to use check list ...

Companies [1415 Associated Companies listed on BioPortfolio]

NC GlaxoSmithKline Foundation

North Carolina GlaxoSmithKline Foundation

GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation pro...

GlaxoSmithKline & Prosensa

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enablin...

The Global Health Investment Fund

GHIF is a private investment fund structured by JPMorgan Chase & Co. and the Bill & Melinda Gates Foundation. The fund received anchor support from Grand Challenges Canada (fun...

More Information about "NC GlaxoSmithKline Foundation" on BioPortfolio

We have published hundreds of NC GlaxoSmithKline Foundation news stories on BioPortfolio along with dozens of NC GlaxoSmithKline Foundation Clinical Trials and PubMed Articles about NC GlaxoSmithKline Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NC GlaxoSmithKline Foundation Companies in our database. You can also find out about relevant NC GlaxoSmithKline Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record